Synthesis and structure–activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor
摘要:
A series of benzylic piperazines (e.g., 4 and 5) attached to an 'address element', the dipeptide H-D-TiC-D-p-Cl-Phe-OH, 3 has been identified as ligands for the melanocortin subtype-4 receptor (MC4R). We describe herein the structure-activity relationship (SAR) studies on the N-terminal residue of the 'address element'. Several novel dipeptides and reduced dipeptides with high MC4R binding affinities and selectivity emerged from this SAR study. (C) 2005 Elsevier Ltd. All rights reserved.
Synthesis and structure–activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor
摘要:
A series of benzylic piperazines (e.g., 4 and 5) attached to an 'address element', the dipeptide H-D-TiC-D-p-Cl-Phe-OH, 3 has been identified as ligands for the melanocortin subtype-4 receptor (MC4R). We describe herein the structure-activity relationship (SAR) studies on the N-terminal residue of the 'address element'. Several novel dipeptides and reduced dipeptides with high MC4R binding affinities and selectivity emerged from this SAR study. (C) 2005 Elsevier Ltd. All rights reserved.
[EN] MELANOCORTIN RECEPTOR AGONISTS<br/>[FR] AGONISTES DU RECEPTEUR DE LA MELANOCORTINE
申请人:LILLY CO ELI
公开号:WO2003061660A1
公开(公告)日:2003-07-31
The present invention relates to melanocortin receptor agonist of the formula (I): which is useful in the treatment for obesity, diabetes, and male and/or female sexual dysfunction.
The present invention relates to melanocortin receptor agonist of the formula I useful in the treatment of obesity, diabetes, and male and/or female sexual dysfunction
1